Abstract
A greater susceptibility to the adverse effects of protease inhibitors is just one of many possible reasons that highly active antiretroviral therapy has been less beneficial in women. How can you ensure that treatment is optimal?
| Original language | English (US) |
|---|---|
| Pages (from-to) | 187-201 |
| Number of pages | 15 |
| Journal | Patient Care |
| Volume | 33 |
| Issue number | 6 |
| State | Published - Mar 30 1999 |
ASJC Scopus subject areas
- Leadership and Management
